Inactive Instrument

Insiders Pharmacyte Biotech Inc Other OTC

Equities

US67090R1005

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-23	MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	CI
03-18	PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmaCyte Biotech, Inc. Announces Resignation of Jack E. Stover as Director	22-11-07	CI
PharmaCyte Biotech, Inc. Announces Resignation of Gerald W. Crabtree as Chief Scientific Officer	22-10-14	CI
PharmaCyte Biotech, Inc. Announces Management Changes	22-10-07	CI
PharmaCyte Biotech CEO Kenneth Waggoner Resigns; Board Forms Business Review Committee; Shares Rise	22-10-07	MT
PharmaCyte Biotech, Inc. Announces Management Changes	22-10-07	CI
PharmaCyte Biotech Reaches Agreement With Iroquois to Appoint Two Directors to Board	22-08-15	MT
PharmaCyte Biotech, Inc. Announces Board Appointments	22-08-15	CI
Iroquois Capital Management Nominates Candidates to the Board of PharmaCyte Biotech	22-06-23	CI
PharmaCyte Biotech, Inc. Appoints Matthias Löhr to the Board	22-04-05	CI
PharmaCyte Biotech, Inc. Announces Dr. Gerald W. Crabtree Will No Longer Serve as Chief Operating Officer But Instead Will Serve as Chief Scientific Officer	20-10-16	CI
PharmaCyte Biotech, Inc. Appoints José Iglesias as Consulting Chief Medical Officer for Clinical Trial in Pancreatic Cancer	20-08-10	CI
PharmaCyte Biotech, Inc. Names David A. Judd to Medical and Scientific Advisory Board	19-07-15	CI
PharmaCyte Biotech, Inc. Appoints Raymond C.F. Tong, M.D. to the Board	17-10-10	CI
PharmaCyte Biotech, Inc. Appoints Alan as Strategic Advisor	17-09-13	CI
PharmaCyte Biotech, Inc. Appoints Linda S. Sher as its Chief Medical Officer	17-07-26	CI
PharmaCyte Biotech, Inc. Appoints Michael M. Abecassis to the Board	17-07-10	CI
PharmaCyte Biotech, Inc. Appoints Thomas Yuen to Board of Directors	17-05-02	CI
PharmaCyte Biotech, Inc. Appoints Mark Rabe Director of Cannabis Program Development	17-04-03	CI
PharmaCyte Biotech, Inc. Appoints Leonard Makowka as Senior Strategic Advisor	17-03-13	CI
PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity	17-02-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Pharmacyte Biotech Inc Other OTC

Equities

US67090R1005

Insiders

Filters